Portugal - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)
Since 2014, Portugal Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) was down by 12.9% year on year. In 2019, the country was number 23 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) with €0.03 Per Capita. Switzerland lead the ranking with €665.57 Per Capita in 2019, that is a growth of 3.2% versus 2018. Germany, Liechtenstein and Belgium respectively ranked number 2, 3 and 4 in this ranking. Switzerland witnessed the best average annual growth at +5.4% per year, while Portugal was the worst growing country at -12.9% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 0.03 |
2018 | 0.06 |
2017 | 0.06 |
2016 | 0.05 |
2015 | 0.05 |
How does Portugal rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?
# | 23 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Switzerland
|
665.57 | 2019 | +3.1 % | +5.3 % | View data | |
2 |
#2
Germany
|
524.79 | 2019 | +2.3 % | +3.0 % | View data | |
22 |
#22
Spain
|
10.47 | 2019 | +0.3 % | +0.8 % | View data | |
23 |
#23
Portugal
|
0.03 | 2019 | -50.0 % | -12.9 % | View data |